share_log

赛隆药业(002898.SZ):赖氨匹林获得化学原料药上市申请批准通知书

Cailong Pharmaceutical (002898.SZ): Lysapirine received a notice of approval for the marketing application of chemical raw materials

Gelonghui Finance ·  May 24 03:45

Gelonghui, May 24 | Sailong Pharmaceutical (002898.SZ) announced that its wholly-owned subsidiary Hunan Sailong Pharmaceutical Co., Ltd. recently obtained the “Notice of Approval of the Application for the Marketing of Chemical Ingredients” for lysapillin approved and issued by the State Drug Administration. The main indications for lysapirine are: it is used to treat fever and mild to moderate pain.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment